Evidence map›Paper›PMID 22577035›Full record

ArticleArthritis and rheumatism2012

Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes.

Jaya Vas, Caroline Grönwall, Ann Marshak-Rothstein, Gregg J Silverman

Abstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Loss of an IgG plasma cell checkpoint in patients with lupus.The Journal of allergy and clinical immunology · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jaya VasNew York University School of Medicine, New York, New York 10016, USA.
Caroline Grönwall
Ann Marshak-Rothstein
Gregg J Silverman
New York University · USUniversity of Massachusetts Chan Medical School · US

Funding

Toll-Like Receptors in Systemic Autoimmune DiseaseP01AR050256 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHLOMCHIK, MARK J · 2004 to 2013
$13.4M
Cell Death and Antibody-Mediated Protection from AutoimmunityR01AI068063 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2006 to 2010
$2.1M
Lupus and the inhibitory dual receptor hypothesisR01AI090118 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2010 to 2014
$2.0M
Mechanisms to Induce Protective Natural AutoimmunityR21AR050659 · NIAMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2003 to 2004
$152k
NIAID NIH HHS R01 AI068063NIAID NIH HHS R01-AI-068063NIAID NIH HHS R01 AI090118NIAID NIH HHS R01-AI-090118NIAMS NIH HHS P01 AR050256NIAMS NIH HHS R21 AR050659
6 · The paper itself

Abstract

objectiveNaturally arising IgM antibodies (NAb) to apoptotic cell (AC) determinants are present from birth and can be further induced by AC challenge. In systemic lupus erythematosus, lower anti-AC NAb levels have been associated with higher disease activity. We have recently shown that a prototypical AC-specific IgM NAb can suppress proinflammatory responses to purified agonists of Toll-like receptors and block the in vivo induction of IgG immune complex (IC)-induced arthritis. Nuclear antigens, which activate dendritic cells (DCs), form complexes with IgG autoantibody, and these have been implicated in the pathogenesis of autoimmune disease. In this study, we sought to investigate potential roles of such NAb for regulating IC-mediated activation of DCs, which is believed to be involved in disease initiation and perpetuation.

methodsBone marrow-derived myeloid DCs were stimulated with ICs composed of IgG autoantibody and chromatin or IgG autoantibody and RNA. Outcome was evaluated according to the production of inflammatory cytokines, as determined by enzyme-linked immunosorbent assay, and the expression of costimulatory molecules (markers of DC activation), as determined by flow cytometry. MAPK activation was evaluated by phospho-flow analysis and immunofluorescence microscopy.

resultsIgM anti-AC NAb dose-dependently suppressed the production of DNA IC- and RNA IC-induced interleukin-6 and DNA IC-induced tumor necrosis factor α, as well as the RNA IC-induced up-regulation of CD86 and CD40 on DCs. IgM NAb-mediated inhibition was associated with suppression of IC-mediated p38 MAPK activation and nuclear localization.

conclusionWe demonstrated a direct in vitro inhibitory effect of IgM NAb on inflammatory responses induced by IgG-nucleic acid ICs. These findings contribute to emerging evidence that regulatory NAb to AC determinants may oppose the influence of pathogenic lupus autoantibody ICs and thereby play roles in the maintenance of immune homeostasis.

Indexed as

AnimalsAntigen-Antibody ComplexApoptosisAutoantibodiesCell MembraneDendritic CellsImmunoglobulin MLupus Erythematosus, SystemicMiceAntigen-Antibody ComplexAutoantibodiesImmunoglobulin M

Identifiers

PMID22577035
PMCPMC3462267
OpenAlexW1970098267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.